Digest Network Come funziona
Network
/
Società
RE
Non verificato

REVEAL GENOMICS, S.L.

Di cosa scriviamo

BiotecnologiaIndustriaOncologiaSaluteVetrine/Shopping

4 comunicati stampa

Guarda tutti i comunicati
04/11/2025
Industria
Tecnica
Farmaceutica
Oncologia
Terza età
Sanità
Scienza
Biotecnologia
Software
Vetrine/Shopping
Salute
Nature Communications Study Supports HER2DX as a Genomic Tool for Tailored Therapy in Older Individuals With HER2+ Breast Cancer
Fonte
REVEAL GENOMICS, S.L.
Emittente
Business Wire
1.00
0
27/05/2025
ASCO 2025: REVEAL GENOMICS Unveils New HER2DX Data From 800+ Patients
Fonte
REVEAL GENOMICS, S.L.
Emittente
Business Wire
1.00
0
10/03/2025
Industria
Oncologia
Salute
Sanità
Biotecnologia
Medicina - Varie
Groundbreaking Study Confirms Clinical Decision Impact of HER2DX® Genomic Assay in Early-Stage HER2-Positive Breast Cancer
Fonte
REVEAL GENOMICS, S.L.
Emittente
Business Wire
1.00
0
13/01/2025
REVEAL GENOMICS® Links Immune Tumor Response to Longevity in Breast Cancer Survivors
Fonte
REVEAL GENOMICS, S.L.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0